Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07472842

Study on the Outcomes of Patients Treated in Gynecological Emergency Departments for Pelvic Endometriosis or Suspected Pelvic Endometriosis

Adult patients consulting the gynecological emergency department of CHI Créteil during the inclusion period for endometriosis or symptoms suggestive of endometriosis

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Endometriosis Chronic Gynaecological Disease Dysmenorrhea Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Genital Diseases Genital Diseases, Female Infertility Menstruation Disturbances Neurologic Manifestations Pain Pathologic Processes Pathological Conditions, Signs and Symptoms Pelvic Pain Pelvic Pain Syndrome Signs and Symptoms Urogenital Diseases

Age range

18 year and older

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

About this study

Endometriosis is defined as the presence outside the uterine cavity of tissue similar to the uterine mucosa, which will be affected by hormonal changes during each subsequent menstrual cycle. Endometriosis is thus responsible for pelvic pain, which can be particularly incapacitating, as well as other symptoms depending on the location of the lesions. In some cases, endometriosis is also responsible for infertility. Symptoms have a considerable impact on the quality of life of sufferers, affecting not only their personal and marital lives, but also their professional and social lives.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult patient (aged 18 or over)
  • Patient consulting the gynecological emergency department at Créteil Hospital for
  • Known endometriosis or
  • Symptoms suggestive of endometriosis: dysmenorrhea, pelvic pain, cyclic dysuria, dyspareunia, cyclic dyschezia, infertility, rectal bleeding, chest pain, catamenial hematuria
  • Patient who speaks French and is able to understand the information sheet

Exclusion criteria

  • Minor or menopausal patient
  • Pregnant and breastfeeding patient
  • Other reason for consultation
  • Patient refusal
  • Patient not affiliated with a social security system
  • Patient cannot be contacted for the 3-months questionnaire

Treatment and study plan

Emergency care for endometriosis

Diagnostic Test

Emergency care for endometriosis

  • Introduction of specific treatment for endometriosis
  • Scheduled or completed specialist consultation (gynecologist, surgeon, midwife, radiologist)
  • Pelvic imaging examination scheduled or completed since the gynecological emergency consultation

Primary outcomes

  1. Assessing the impact of treatment in gynecological emergency departments on patients with endometriosis or suspected endometriosis

    Time frame: At 3 months

    Composite criteria : number of specific hormonal or analgesic treatment introduiced for endometriosis according to ESHRE guideline endometriosis

  2. Assessing the impact of treatment in gynecological emergency departments on patients with endometriosis or suspected endometriosis

    Time frame: At 3 months

    Composite criteria : number of scheduled or completed specialist consultation (gynaecologist, surgeon, midwife, radiologist)

  3. Assessing the impact of treatment in gynecological emergency departments on patients endometriosis or suspected endometriosis

    Time frame: At 3 months

    Composite criteria : number of Pelvic imaging recommanded for diagnostic or follow up of endometriosis, according to ESHRE guideline, scheduled or completed since the gynecological emergency consultation

  4. Assessing the impact of deprivation on the future of patients after consultation at gynaecological emergency departments.

    Time frame: At 3 months

    EPICE Scores (Evaluation of Deprivation and Inequalities in Health Examination Centers)

Study contacts

Contact information is provided by the study sponsor or research team.

Yann SALHI, MD

CONTACT

[email protected]

01 57 02 20 00 ext. 8456

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Intercommunal Creteil

Other

Registry information

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Mar 16, 2026
Registry last updated
Mar 16, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.